North American Spine Society Journal (NASSJ), 2023 · DOI: https://doi.org/10.1016/j.xnsj.2023.100235 · Published: June 8, 2023
Spinal cord injury (SCI) is a serious condition that can lead to significant personal, social, and economic challenges. The most common type of traumatic SCI occurs in the neck area, resulting in major sensory, motor, and autonomic problems. Following the initial injury, further damage can occur due to inflammation and other processes that cause neuronal and glial cell death. Additionally, spinal interneurons can undergo changes that can either help or hinder functional recovery. Current treatments include early surgery, blood pressure management, and rehabilitation. Researchers are also exploring neuroregenerative strategies such as using neural stem cells, stem cell transplantation, combinatorial approaches, and cell reprogramming to enhance tissue repair after SCI.
Further optimization of regenerative strategies will lead to standardized personalized treatment options for SCI patients.
Combining regenerative approaches with current standard of care guidelines will target various aspects of secondary injury, improving sensorimotor functional recovery.
The advancements in regenerative medicine aim to enhance patient quality of life following SCI.